Elevance Health (ELV) Stock Looks Reasonable After Raised Earnings Outlook

Detailed summary

Elevance Health has delivered a strong run over the past year, which puts fresh focus on whether the current share price lines up with what its earnings can reasonably support.…

Elevance Health has delivered a strong run over the past year, which puts fresh focus on whether the current share price lines up with what its earnings can reasonably support. With the stock now well above where it traded a few years ago, investors are increasingly asking if the earnings engine is doing enough work to justify that move.

The issue now is whether Elevance Health's current valuation is properly backed by its earnings power today and the profit trajectory implied by recent guidance on margins and growth.

If you want a wider lens on companies where earnings are central to the story, run the same check across 31 high quality undervalued stocks.

The P/E ratio suits Elevance Health because earnings are central to how investors value a large, mature insurer. The stock trades on about 18.1x earnings, which is well below the broader Healthcare sector on 25.3x and also under the peer group near 31.4x. That gap implies the market assigns a lower valuation to Elevance Health's profit stream than to many comparable businesses in the same space.

Because the fair multiple estimate already factors in Elevance Health's size, margins, growth profile and risks, a current P/E below that implied level indicates the stock screens as undervalued on this metric. Despite the recent lawsuit over alleged fraudulent billing putting a spotlight on risk controls, the market is still pricing the shares at a discount to sector norms and to what this framework suggests could be justified. Explore the numbers behind Elevance Health's P/E valuation.

Simply Wall St Narratives pick up where the valuation puzzle around Elevance Health leaves off by spelling out which assumptions on future growth, margins and earnings would need to hold for the stock to look materially richer or cheaper than the current price, and they sit on the platform's Community page.

Elevance Health splits opinion between those who see disciplined execution setting up a margin story and those who think policy and…

This…

The…

Opening of the article, excerpted from Yahoo Finance. To read the rest, open the article on the publisher's site.